Healthcare
ByCan Novo Nordisk’s Newly EU-Approved Wegovy Pill Make Weight Loss Treatment as Simple as Taking a Daily Tablet for Millions Across Europe?
Key Highlights A Landmark Shift From Injection to Tablet The European Commission’s authorization marks the first time a…
Is Eli Lilly’s Reported $2 Billion Pursuit of AtaiBeckley About to Redefine the Future of Psychedelic Medicine?
Key Highlights A Premium Bet on Psychedelic Innovation Eli Lilly is negotiating a takeover of AtaiBeckley at a…
Can Aspira Women’s Health and Cleveland Clinic’s New AI Alliance Rewrite the Rules for Women’s Diagnostics Across Ovarian Cancer and Beyond?
Key Highlights A Strategic Alliance Built for Scale Aspira Women’s Health and Cleveland Clinic have entered a comprehensive…
Will Big Pharma’s Billion-Dollar AI Investments Reshape the US$2 Trillion Pharmaceutical Industry Faster Than the Next Blockbuster Drug?
Key Highlights The AI Investment Race Has Officially Begun Artificial intelligence has rapidly evolved from an experimental technology…
Approved Two Months Early, Can GSK’s Jideytro Become the Blueprint for Faster Breakthrough Therapies in NSCLC?
Key Highlights A Landmark Approval Reflecting the Strength of GSK’s Oncology Push GSK’s announcement that the FDA has…
Can Insilico Medicine’s 9-Month AI Drug Discovery Record in China Rewrite the Global Timeline for Bringing New Medicines to Patients?
Key Highlights A Landmark Shift in How Fast New Medicines Can Reach Patients Insilico Medicine’s disclosure that it…
